Kadimastem Ltd
KDST
Kedudukan dalam Saham
#40943
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Harga Saham
$12.16
Disegerakkan terakhir: 2025-10-30
Modal Pasaran
$50.98K
Perubahan (1 hari)
-0.10%
Perubahan (1 tahun)
69.56%
Negara
IL
Perdagangan Kadimastem Ltd (KDST)
Kategori
Healthcare
Sejarah harga saham bagi Kadimastem Ltd (KDST)
Harga penutupan tertinggi: $3.43 pada 2025-12-01
Harga penutupan terendah: $8.68 pada 2021-01-01
Harga penutupan terendah: $8.68 pada 2021-01-01
Sejarah harga saham Kadimastem Ltd dari 2021 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 29.04% |
| 2025 | -62.21% |
| 2024 | -1.52% |
| 2023 | 0.00% |
| 2022 | -67.49% |
| 2021 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $136.67 | -4.47% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
